Abstract A69: Phase 1/1b study of the FAK inhibitor defactinib (VS-6063) in combination with weekly paclitaxel for advanced ovarian cancer von Patel, Manish R., Infante, Jeffrey R., Moore, Kathleen N., Keegan, Mitchell, Poli, Anne, Padval, Mahesh, Jones, Suzanne Fields, Horobin, Joannna, Burris, Howard A.

Volltext